Consultation: Proposed change to the veterinary omeprazole listing on the Prescription Drug List (PDL)
Current status: Open
Opened on May 13, 2026 and will close to new input on July 27, 2026.
Health Canada is consulting Canadians on the proposal to allow certain veterinary drugs that contain omeprazole to be sold without a prescription. This consultation provides an opportunity to comment on a proposed change to the “omeprazole or its salts” listing on the veterinary use part of the Prescription Drug List (PDL). The proposal applies only to the veterinary listing.
How to get involved
This consultation is open for comment from May 13, 2026 to July 27, 2026 (75 calendar days). Please send your comments on this proposed change to the Prescription Drug List, preferably in electronic format, within 75 days from the date of this notice to:
Health Canada
Prescription Drug Status Committee
6th Floor Holland Cross – Tower B
Address locator: 3106C
1600 Scott Street
Ottawa ON K1A 0K9
Email: drug.prescription.status-statut.dordonnance.des.drogues@hc-sc.gc.ca
Who is the focus of this consultation
We will engage with:
- academics
- health professionals
- industry
- members of the public
- any other interested stakeholders
Related information
- Notice of changes to the Prescription Drug List
- Guidance Document: Determining Prescription Status for Human and Veterinary Drugs
Contact us
Health Canada
Prescription Drug Status Committee
6th Floor Holland Cross – Tower B
Address locator: 3106C
1600 Scott Street
Ottawa ON K1A 0K9
Email: drug.prescription.status-statut.dordonnance.des.drogues@hc-sc.gc.ca